| ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
| EEF1B2P2 |
|
eukaryotic translation elongation factor 1 beta 2 pseudogene 2
|
|
|
0.612 |
0.577 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
| THAS |
|
thoracoabdominal syndrome
|
|
|
0.560 |
0.808 |
| UGT1A |
|
UDP glucuronosyltransferase family 1 member A complex locus
|
|
|
0.540 |
0.654 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| SNHG1 |
|
small nucleolar RNA host gene 1
|
|
|
0.576 |
0.692 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| BRCA3 |
|
breast cancer 3
|
|
|
0.705 |
0.269 |
| AFAP1-AS1 |
|
AFAP1 antisense RNA 1
|
|
|
0.573 |
0.538 |
| CKS1BP7 |
|
CDC28 protein kinase regulatory subunit 1B pseudogene 7
|
|
|
0.610 |
0.577 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| CRYGEP |
|
crystallin gamma E, pseudogene
|
|
|
0.666 |
0.538 |
| NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
| SNHG15 |
|
small nucleolar RNA host gene 15
|
|
|
0.633 |
0.615 |
| PWAR4 |
|
Prader Willi/Angelman region RNA 4
|
|
|
0.573 |
0.769 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| BCAR4 |
|
breast cancer anti-estrogen resistance 4
|
|
|
0.653 |
0.346 |